Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Aug;33(8):1997–2001. doi: 10.1128/jcm.33.8.1997-2001.1995

Evaluation of commercial antisera for Shigella serogrouping.

J Lefebvre 1, F Gosselin 1, J Ismaïl 1, M Lorange 1, H Lior 1, D Woodward 1
PMCID: PMC228323  PMID: 7559936

Abstract

Shigella serogrouping antisera from six companies (Becton Dickinson, Denka, Difco, Murex, Roach, and Sanofi-Pasteur) intended for the slide agglutination test and those of the Wellcolex Colour Shigella latex agglutination test were evaluated to identify quality products for Shigella identification. Forty-six reference Shigella strains (one for each serotype and species), 50 clinical strains (21 S. flexneri, 21 S. sonnei, 4 S. dysenteriae, 4 S. boydii) representing the most prevalent species and serotypes encountered in Quebec, and 9 non-Shigella strains were tested according to the manufacturers' instructions. A 3+ reaction (> or = 75% agglutination) was considered positive for the slide agglutination tests. Sensitivity varied from 47% (Roach) to 94% (Difco). For the 105 strains tested, accuracy ranged from 53% (Roach) to 91% (Wellcolex). Specificity varied from 97 to 100% for group A antisera, from 96 to 100% for group B antisera, from 88 to 100% for group C antisera, and from 95 to 99% for group D antisera. The costs of reagents required to test one strain varied from $3.50 to $13.20 (in Canadian dollars). In conclusion, Roach reagents proved to be unsatisfactory for Shigella serogrouping. Among those from the remaining companies, the Denka, Difco, and Wellcolex reagents met a performance standard of 90% accuracy.

Full Text

The Full Text of this article is available as a PDF (241.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouvet P. J., Jeanjean S. Evaluation of two colored latex kits, the Wellcolex Colour Salmonella Test and the Wellcolex Colour Shigella Test, for serological grouping of Salmonella and Shigella species. J Clin Microbiol. 1992 Aug;30(8):2184–2186. doi: 10.1128/jcm.30.8.2184-2186.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Evins G. M., Gheesling L. L., Tauxe R. V. Quality of commercially produced Shigella serogrouping and serotyping antisera. J Clin Microbiol. 1988 Mar;26(3):438–442. doi: 10.1128/jcm.26.3.438-442.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Green M. S., Block C., Cohen D., Slater P. E. Four decades of shigellosis in Israel: epidemiology of a growing public health problem. Rev Infect Dis. 1991 Mar-Apr;13(2):248–253. doi: 10.1093/clinids/13.2.248. [DOI] [PubMed] [Google Scholar]
  4. Harnett N. Antimicrobial susceptibilities of Shigella species isolated in Ontario in 1990. Can Dis Wkly Rep. 1991 Dec 14;17(50):275–277. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES